Get 20% lifetime commission for referring investors to digrin.com
here.
Inhibikase Therapeutics, Inc. ( IKT) - Stock Earnings
IKT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
IKT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -12.7 million USD | — USD |
| 2026Q1 | -16.4 million USD | — USD |
| 2026Q2 | -19.6 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
IKT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -19.0 million USD | 260500 USD |
| 2024 | -27.5 million USD | — USD |
| 2025 | -48.3 million USD | — USD |
| 2026 Est. | — | — |
IKT
Price: $2.36
52 week price:
Earnings Per Share: -0.44 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 146895
Market Capitalization: 336.3 million